REMODULIN
- CAS No.
- 81846-19-7
- Chemical Name:
- REMODULIN
- Synonyms
- TREPROSTINIL;Orenitram;2-(((1R,2R,3aS,9aS)-2-hydroxy-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl)oxy)acetic acid;UT-15;LRX 15;U 62840;15AU-81;BW 15AU;Uniprost;Ruidulin
- CBNumber:
- CB7231250
- Molecular Formula:
- C23H34O5
- Molecular Weight:
- 390.51
- MDL Number:
- MFCD00888847
- MOL File:
- 81846-19-7.mol
- MSDS File:
- SDS
Melting point | 121-123° |
---|---|
Boiling point | 587.1±50.0 °C(Predicted) |
Density | 1.158±0.06 g/cm3(Predicted) |
storage temp. | Sealed in dry,Store in freezer, under -20°C |
solubility | Chloroform (Slightly, Heated), Methanol (Slightly, Heated) |
form | Solid |
pka | 3.19±0.10(Predicted) |
color | Off-White to Beige |
FDA UNII | RUM6K67ESG |
ATC code | B01AC21 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS06,GHS08 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H301-H311-H331-H361 | |||||||||
Precautionary statements | P501-P270-P202-P201-P264-P280-P308+P313-P362+P364-P301+P310+P330-P302+P352+P312-P405 | |||||||||
NFPA 704 |
|
REMODULIN price More Price(20)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 10162 | Treprostinil ≥98% | 81846-19-7 | 1mg | $97 | 2024-03-01 | Buy |
Cayman Chemical | 10162 | Treprostinil ≥98% | 81846-19-7 | 5mg | $433 | 2024-03-01 | Buy |
Cayman Chemical | 10162 | Treprostinil ≥98% | 81846-19-7 | 10mg | $768 | 2024-03-01 | Buy |
Tocris | 5349 | Treprostinil ≥98%(HPLC) | 81846-19-7 | 10 | $270 | 2021-12-16 | Buy |
TRC | T719500 | Treprostinil | 81846-19-7 | 10mg | $615 | 2021-12-16 | Buy |
REMODULIN Chemical Properties,Uses,Production
Uses
Synthetic analog of Prostacyclin (P839060). Antihypertensive. Treprostinil, marketed under the trade name Remodulin is a medication used to treat pulmonary arterial hypertension (PAH).
Definition
ChEBI: Treprostinil is a carboxylic acid and a carbotricyclic compound. It has a role as a platelet aggregation inhibitor, a vasodilator agent, an antihypertensive agent, a cardiovascular drug, a vitamin K antagonist and a human blood serum metabolite.
Pharmacokinetics
Treprostinil is rapidly absorbed from the subcutaneous site of infusion, with an almost 100% bioavailability and a mean half-life of 85 minutes (34 minutes for the IV infusion). The IV solution must be diluted with normal saline or sterile water before starting the infusion. Unlike epoprostenol, treprostinil is stable at room temperature for up to 5 years, with vasodilation action lasting from 4 to 6 hours, compared with the short, 2- to 3-minute action for epoprostenol. Because of its long life in the body, it can be administered under the skin with a microinfusion subcutaneous infusion pump rather than into the bloodstream and, thus, without hospitalization, as contrasted with the central IV infusion of epoprostenol.
Clinical Use
Treprostinil is a synthetic, stable form of prostacyclin for the treatment for advanced pulmonary hypertension with NYHA class III or IV symptoms as well as for late-stage peripheral vascular disease (PVD). Its sodium salt injectable form is administered either as a continuous subcutaneous infusion directly into the skin or, if the subcutaneous infusion is not tolerated, as a continuous IV infusion without an implanted catheter.
Side effects
Side effects include jaw pain, headaches, nausea, diarrhea, flushing, and localized pain at the delivery site under the skin. This pain has been reported as slight to severe irritation. Patients using the drug seem to ex-perience improvement in their condition, including decreased fatigue, decreased shortness of breath, and decreased pulmonary artery pressures, as well as overall improvement in quality of life.
storage
Store at -20°C
REMODULIN Preparation Products And Raw materials
Raw materials
1of2
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 | fandachem@gmail.com | China | 9333 | 55 |
Shanghai finete Pharmaceutical Co., Ltd. | +86-18221039705 | CHINA | 139 | 55 | |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32836 | 60 |
Lianyungang happen teng technology co., LTD | 15950718863 | wang666xt@163.com | CHINA | 295 | 58 |
Biochempartner | 0086-13720134139 | candy@biochempartner.com | CHINA | 967 | 58 |
Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28180 | 58 |
HubeiwidelychemicaltechnologyCo.,Ltd | 18627774460 | faith@widelychemical.com | CHINA | 742 | 58 |
Hubei xin bonus chemical co. LTD | 86-13657291602 | linda@hubeijusheng.com | CHINA | 22968 | 58 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | sales@chemdad.com | China | 39916 | 58 |